New developments in management of gastrointestinal stromal tumors: regorafenib, the new player in the team
Gastrointestinal Cancer: Targets and Therapy · 2013
DOI: 10.2147/gictt.s20679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastrointestinal Cancer: Targets and Therapy, 2013. Verfasst von Anette Duensing und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Duensing, A., Boichuk, S., & Rausch, J. (2013). New developments in management of gastrointestinal stromal tumors: regorafenib, the new player in the team. Gastrointestinal Cancer: Targets and Therapy. https://doi.org/10.2147/gictt.s20679
Vancouver
Duensing A, Boichuk S, Rausch J. New developments in management of gastrointestinal stromal tumors: regorafenib, the new player in the team. Gastrointestinal Cancer: Targets and Therapy. 2013. doi:10.2147/gictt.s20679
BibTeX
@article{Duensing2013,
author = {Duensing, Anette and Boichuk, Sergei and Rausch, Jessica},
title = {New developments in management of gastrointestinal stromal tumors: regorafenib, the new player in the team},
journal = {Gastrointestinal Cancer: Targets and Therapy},
year = {2013},
doi = {10.2147/gictt.s20679}
}
EUVIMED